Physician profile
Arden Smith
NPI 1508864752
$2,086.68
in general payments reported to CMS, 2019-2025
17 companies · $74.59 in 2025
The $74.59 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $457 · 2021: $442 · 2022: $391 · 2023: $113 · 2024: $165 · 2025: $74.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $352.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $419.30 | 2019-2025 | Oasis |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $331.93 | 2019-2021 | |
| Stryker Corporation | $310.82 | 2020-2021 | |
| Sandoz INC. | $190.75 | 2019-2021 | |
| Kerecis Limited | $186.87 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Melinta Therapeutics, LLC | $173.46 | 2019 | |
| Lifenet Health | $113.14 | 2023 | |
| Zimmer Biomet Holdings, INC. | $80.52 | 2021-2022 | |
| Alfasigma USA, INC. | $57.41 | 2021-2022 | |
| Royal Biologics, INC. | $47.95 | 2020 | |
| Organogenesis INC. | $44.15 | 2021-2022 | |
| Medtronic, INC. | $37.21 | 2022 | |
| Abbvie INC. | $26.82 | 2022 | |
| Kci USA, INC. | $20.06 | 2022 | |
| Djo, LLC | $18.66 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $14.88 | 2019 | |
| Bioventus LLC | $12.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arden Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.